Association between Neutrophil-to-high-density lipoprotein-cholesterol ratio and gallstones: insights from the national health and nutrition examination survey (2017-2020).
Cross-sectional study
Gallstones
High-density lipoprotein-cholesterol
NHANES
Neutrophil-to-high-density lipoprotein-cholesterol ratio
Journal
Lipids in health and disease
ISSN: 1476-511X
Titre abrégé: Lipids Health Dis
Pays: England
ID NLM: 101147696
Informations de publication
Date de publication:
31 Oct 2024
31 Oct 2024
Historique:
received:
29
08
2024
accepted:
26
10
2024
medline:
1
11
2024
pubmed:
1
11
2024
entrez:
1
11
2024
Statut:
epublish
Résumé
Inflammatory responses and lipid metabolism make vital impacts on the development of gallstones. This study investigated the relationship between gallstone disease (GSD) and the neutrophil-to-high-density lipoprotein cholesterol ratio (NHR) in American patients with gallstones. The data analyzed were sourced from the 2017-2020 National Health and Nutrition Examination Survey (NHANES) and comprised of participants with complete data on GSD and NHR. The relationship between NHR and GSD was evaluated with weighted multivariable logistic regression analysis. Additionally, subset analyses, interaction tests, smoothed curve fitting, and threshold effect analyses were conducted. Among the 7894 participants analyzed in this study, the prevalence of GSD was 10.98%, and the average NHR value was 3.41 ± 0.06. The fully adjusted multivariable logistic regression results demonstrated an obvious positive association between NHR and the likelihood of GSD (OR = 1.09, 95% CI: 1.01, 1.16; P = 0.0197). Consistency of this association was confirmed through subset analyses and interaction tests across various subgroups, including those categorized by smoking status and asthma. Furthermore, smoothed curve fitting and threshold effect analyses revealed a nonlinear relationship with a threshold of 2.86. NHR shows a positive relationship to an increased likelihood of GSD among Americans. It can act as an easy and cost-effective tool for the early detection and management of individuals at risk for GSD.
Sections du résumé
BACKGROUND
BACKGROUND
Inflammatory responses and lipid metabolism make vital impacts on the development of gallstones. This study investigated the relationship between gallstone disease (GSD) and the neutrophil-to-high-density lipoprotein cholesterol ratio (NHR) in American patients with gallstones.
METHODS
METHODS
The data analyzed were sourced from the 2017-2020 National Health and Nutrition Examination Survey (NHANES) and comprised of participants with complete data on GSD and NHR. The relationship between NHR and GSD was evaluated with weighted multivariable logistic regression analysis. Additionally, subset analyses, interaction tests, smoothed curve fitting, and threshold effect analyses were conducted.
RESULTS
RESULTS
Among the 7894 participants analyzed in this study, the prevalence of GSD was 10.98%, and the average NHR value was 3.41 ± 0.06. The fully adjusted multivariable logistic regression results demonstrated an obvious positive association between NHR and the likelihood of GSD (OR = 1.09, 95% CI: 1.01, 1.16; P = 0.0197). Consistency of this association was confirmed through subset analyses and interaction tests across various subgroups, including those categorized by smoking status and asthma. Furthermore, smoothed curve fitting and threshold effect analyses revealed a nonlinear relationship with a threshold of 2.86.
CONCLUSIONS
CONCLUSIONS
NHR shows a positive relationship to an increased likelihood of GSD among Americans. It can act as an easy and cost-effective tool for the early detection and management of individuals at risk for GSD.
Identifiants
pubmed: 39482705
doi: 10.1186/s12944-024-02349-w
pii: 10.1186/s12944-024-02349-w
doi:
Substances chimiques
Cholesterol, HDL
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
355Informations de copyright
© 2024. The Author(s).
Références
Farthing M, Roberts SE, Samuel DG, Williams JG, Thorne K, Morrison-Rees S, et al. <ArticleTitle Language=“En”>Survey of digestive health across Europe: final report. Part 1: the burden of gastrointestinal diseases and the organisation and delivery of gastroenterology services across Europe. United Eur Gastroent. 2014;2:539–43. https://doi.org/10.1177/2050640614554154 .
doi: 10.1177/2050640614554154
Lammert F, Gurusamy K, Ko CW, Miquel J-F, Méndez-Sánchez N, Portincasa P, et al. Gallstones Nat Rev Dis Primers. 2016;2:16024. https://doi.org/10.1038/nrdp.2016.24 .
doi: 10.1038/nrdp.2016.24
pubmed: 27121416
Marschall HU, Einarsson C. Gallstone disease. J Intern Med. 2007;261:529–42. https://doi.org/10.1111/j.1365-2796.2007.01783.x .
doi: 10.1111/j.1365-2796.2007.01783.x
pubmed: 17547709
Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014;6:99–109. https://doi.org/10.2147/CLEP.S37357 .
doi: 10.2147/CLEP.S37357
pubmed: 24634588
Polychronidis G, Siddiqi H, Ali Ahmed F, Papatheodorou S, Giovannucci EL, Song M. Association of gallstone disease with risk of colorectal cancer: a systematic review and meta-analysis of observational studies. Int J Epidemiol. 2023;52:1424–34. https://doi.org/10.1093/ije/dyad042 .
doi: 10.1093/ije/dyad042
pubmed: 37071919
Zhang L, Zhang W-Q, He L, Cui H-J, Wang Y-T, Wu X-Y, et al. Impact of gallstone disease on the risk of stroke and coronary artery disease: evidence from prospective observational studies and genetic analyses. Bmc Med. 2023;21:353. https://doi.org/10.1186/s12916-023-03072-6 .
doi: 10.1186/s12916-023-03072-6
pubmed: 37705021
Lyu J-T, Lin Q-H, Fang Z-B, Xu Z-L, Liu Z-T. Complex impacts of gallstone disease on metabolic syndrome and nonalcoholic fatty liver disease. Front Endocrinol. 2022;13:1032557. https://doi.org/10.3389/fendo.2022.1032557 .
doi: 10.3389/fendo.2022.1032557
Wang X, Yu W-Q, Jiang G-H, Li H-Y, Li S-Y, Xie L-J, et al. Global epidemiology of gallstones in the 21st century: A systematic review and Meta-analysis. Clin Gastroenterol H. 2024;22:1586–95. https://doi.org/10.1016/j.cgh.2024.01.051 .
doi: 10.1016/j.cgh.2024.01.051
Sheng B-W, Zhao Q-B, Ma M, Zhang J-Q. An inverse association of weight and the occurrence of asymptomatic gallbladder stone disease in hypercholesterolemia patients: A case-control study. Lipids Health Dis. 2020;19:228. https://doi.org/10.1186/s12944-020-01402-8 .
doi: 10.1186/s12944-020-01402-8
pubmed: 33097057
Unalp-Arida A, Ruhl CE. Increasing gallstone disease prevalence and associations with gallbladder and biliary tract mortality in the US. Hepatology. 2023;77:1882–95. https://doi.org/10.1097/HEP.0000000000000264 .
doi: 10.1097/HEP.0000000000000264
pubmed: 36631004
Figueiredo JC, Haiman C, Porcel J, Buxbaum J, Stram D, Tambe N, et al. Sex and ethnic/racial-specific risk factors for gallbladder disease. Bmc Gastroenterol. 2017;17:153. https://doi.org/10.1186/s12876-017-0678-6 .
doi: 10.1186/s12876-017-0678-6
pubmed: 29221432
pmcid: 5723039
Everhart JE, Ruhl CE. Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas. Gastroenterology. 2009;136:1134–44. https://doi.org/10.1053/j.gastro.2009.02.038 .
doi: 10.1053/j.gastro.2009.02.038
pubmed: 19245868
Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, et al. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122:1500–11. https://doi.org/10.1053/gast.2002.32978 .
doi: 10.1053/gast.2002.32978
pubmed: 11984534
Yuan S, Gill D, Giovannucci EL, Larsson SC. Obesity, type 2 diabetes, lifestyle factors, and risk of gallstone disease: a Mendelian randomization investigation. Clin Gastroenterol H. 2022;20:e529–37. https://doi.org/10.1016/j.cgh.2020.12.034 .
doi: 10.1016/j.cgh.2020.12.034
Liu Z-C, Liu S, Song P-Z, Jiao Y. Mendelian randomization study on the causal relationship between food and cholelithiasis. Front Nutr. 2024;11:1276497. https://doi.org/10.3389/fnut.2024.1276497 .
doi: 10.3389/fnut.2024.1276497
pubmed: 38501068
pmcid: 10944874
Maurer KJ, Carey MC, Fox JG. Roles of infection, inflammation, and the immune system in cholesterol gallstone formation. Gastroenterology. 2009;136:425–40. https://doi.org/10.1053/j.gastro.2008.12.031 .
doi: 10.1053/j.gastro.2008.12.031
pubmed: 19109959
Zhang M, Mao M, Zhang C, Hu F-L, Cui P, Li G-C, et al. Blood lipid metabolism and the risk of gallstone disease: a multi-center study and meta-analysis. Lipids Health Dis. 2022;21:26. https://doi.org/10.1186/s12944-022-01635-9 .
doi: 10.1186/s12944-022-01635-9
pubmed: 35236330
Jiang M, Sun J-Y, Zou H-Y, Li M-H, Su Z-Y, Sun W, et al. Prognostic role of neutrophil to high-density lipoprotein cholesterol ratio for all-cause and cardiovascular mortality in the general population. Front Cardiovasc Med. 2022;9:807339. https://doi.org/10.3389/fcvm.2022.807339 .
doi: 10.3389/fcvm.2022.807339
pubmed: 35211525
Qing G-W, Bao C, Yang Y-J, Wei B. Association between neutrophil to high-density lipoprotein cholesterol ratio (NHR) and depression symptoms among the United States adults: a cross-sectional study. Lipids Health Dis. 2024;23:215. https://doi.org/10.1186/s12944-024-02204-y .
doi: 10.1186/s12944-024-02204-y
pubmed: 39003458
Yang L, He C-Y, Wang W. Association between neutrophil to high-density lipoprotein cholesterol ratio and disease severity in patients with acute biliary pancreatitis. Ann Med. 2024;56:2315225. https://doi.org/10.1080/07853890.2024.2315225 .
doi: 10.1080/07853890.2024.2315225
pubmed: 38335727
Shi K, Hou J, Zhang Q, Bi Y-F, Zeng X-W, Wang X-B. Neutrophil-to-high-density-lipoprotein- cholesterol ratio and mortality among patients with hepatocellular carcinoma. Front Nutr. 2023;10:1127913. https://doi.org/10.3389/fnut.2023.1127913
Liu Z, Kemp TJ, Gao YT, Corbel A, McGee EE, Wang B, et al. Association of circulating inflammation proteins and gallstone disease. J Gastroen Hepatol. 2018;33:1920–4. https://doi.org/10.1111/jgh.14265 .
doi: 10.1111/jgh.14265
Liew PX, Kubes P. The neutrophil’s role during health and disease. Physiol Rev. 2019;99:1223–48. https://doi.org/10.1152/physrev.00012.2018 .
doi: 10.1152/physrev.00012.2018
pubmed: 30758246
Tall AR, Yvan-Charvet L. Cholesterol, inflammation and innate immunity. Nat Rev Immunol. 2015;15:104–16. https://doi.org/10.1038/nri3793 .
doi: 10.1038/nri3793
pubmed: 25614320
Huang J-B, Chen Y-S, Ji H-Y, Xie W-M, Jiang J, Ran L-S, et al. Neutrophil to high-density lipoprotein ratio has a superior prognostic value in elderly patients with acute myocardial infarction: a comparison study. Lipids Health Dis. 2020;19:59. https://doi.org/10.1186/s12944-020-01238-2 .
doi: 10.1186/s12944-020-01238-2
pubmed: 32247314
Liu Z, Fan Q-L, Wu S-Z, Wan Y-Q, Lei Y-C. Compared with the monocyte to high-density lipoprotein ratio (MHR) and the neutrophil to lymphocyte ratio (NLR), the neutrophil to high-density lipoprotein ratio (NHR) is more valuable for assessing the inflammatory process in Parkinson’s disease. Lipids Health Dis. 2021;20:35. https://doi.org/10.1186/s12944-021-01462-4 .
doi: 10.1186/s12944-021-01462-4
pubmed: 33874966
Meng C-L, Liu K. Higher levels of systemic immune-inflammatory index are associated with the prevalence of gallstones in people under 50 years of age in the United States: a cross-sectional analysis based on NHANES. Front Med. 2024;10:1320735. https://doi.org/10.3389/fmed.2023.1320735 .
doi: 10.3389/fmed.2023.1320735
Kler A, Taib A, Hajibandeh S, Hajibandeh S, Asaad P. The predictive significance of neutrophil-to- lymphocyte ratio in cholecystitis: a systematic review and meta-analysis. Langenbeck Arch Surg. 2021;407:927–35. https://doi.org/10.1007/s00423-021-02350-2 .
doi: 10.1007/s00423-021-02350-2
Cho SK, Jung S, Lee KJ, Kim JW. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio can predict the severity of gallstone pancreatitis. Bmc Gastroenterol. 2018;18:18. https://doi.org/10.1186/s12876-018-0748-4 .
doi: 10.1186/s12876-018-0748-4
pubmed: 29370777
Fu C, Li X-C, Wang Y-X, Chen J-H, Yang Y-B, Liu K. Association between triglyceride glucose index-related indices with gallstone disease among US adults. Lipids Health Dis. 2024;23:203. https://doi.org/10.1186/s12944-024-02194-x .
doi: 10.1186/s12944-024-02194-x
pubmed: 38937793
pmcid: 11210093
Akboga MK, Canpolat U, Yuksel M, Yayla C, Yilmaz S, Turak O, et al. Platelet to lymphocyte ratio as a novel indicator of inflammation is correlated with the severity of metabolic syndrome: A single center large-scale study. Platelets. 2016;27:178–83. https://doi.org/10.3109/09537104.2015.1064518 .
doi: 10.3109/09537104.2015.1064518
pubmed: 26196312
Wu S, Lin H-Y, Zhang C-Q, Zhang Q, Zhang D-Z, Zhang Y-Y, et al. Association between erythrocyte parameters and metabolic syndrome in urban Han Chinese: a longitudinal cohort study. BMC Public Health. 2013;13:989. https://doi.org/10.1186/1471-2458-13-989 .
doi: 10.1186/1471-2458-13-989
pubmed: 24144016
pmcid: 4016498
Chen L-L, Qiu W, Sun X-D, Gao M-H, Zhao Y-X, Li M-Y, et al. Novel insights into causal effects of serum lipids and lipid-modifying targets on cholelithiasis. Gut. 2024;73:521–32. https://doi.org/10.1136/gutjnl-2023-330784 .
doi: 10.1136/gutjnl-2023-330784
pubmed: 37945330
Janowitz P, Wechsler JG, Kuhn K, Kratzer W, Tudyka J, Swobodnik W, et al. The relationship between serum lipids, nucleation time, and biliary lipids in patients with gallstones. Clin Investigator. 1992;70:430–6. https://doi.org/10.1007/BF00235527 .
doi: 10.1007/BF00235527
Thornton JR, Heaton KW, Macfarlane DG. A relation between high-density-lipoprotein cholesterol and bile cholesterol saturation. Br Med J (Clin Res Ed). 1981;283:1352–4. https://doi.org/10.1136/bmj.283.6303.1352 .
doi: 10.1136/bmj.283.6303.1352
pubmed: 6797538
Muñoz LE, Boeltz S, Bilyy R, Schauer C, Mahajan A, Widulin N, et al. Neutrophil extracellular traps initiate gallstone formation. Immunity. 2019;51. https://doi.org/10.1016/j.immuni.2019.07.002 . :443 – 50.e4.
Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol. 2018;18:134–47. https://doi.org/10.1038/nri.2017.105 .
doi: 10.1038/nri.2017.105
pubmed: 28990587
Leppkes M, Maueröder C, Hirth S, Nowecki S, Günther C, Billmeier U, et al. Externalized decondensed neutrophil chromatin occludes pancreatic ducts and drives pancreatitis. Nat Commun. 2016;7:10973. https://doi.org/10.1038/ncomms10973 .
doi: 10.1038/ncomms10973
pubmed: 26964500
pmcid: 4793047
Sun H, Warren J, Yip J, Ji Y, Hao S-L, Han W, et al. Factors influencing gallstone formation: a review of the literature. Biomolecules. 2022;12:550. https://doi.org/10.3390/biom12040550 .
doi: 10.3390/biom12040550
pubmed: 35454138
Aune D, Vatten LJ, Boffetta P. Tobacco smoking and the risk of gallbladder disease. Eur J Epidemiol. 2016;31. https://doi.org/10.1007/s10654-016-0124-z . :643 – 53.
Bai Y, Zhang M, Cui H-J, Shan X-F, Gu D-Q, Wang Y-T, et al. Addictive behavior and incident gallstone disease: A dose–response meta-analysis and Mendelian randomization study. Front Nutr. 2022;9:940689. https://doi.org/10.3389/fnut.2022.940689 .
doi: 10.3389/fnut.2022.940689
pubmed: 36299995
Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. Brit Med J. 1989;298:784–8. https://doi.org/10.1136/bmj.298.6676.784 .
doi: 10.1136/bmj.298.6676.784
pubmed: 2496857
Baron JA. Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious. Brit Med Bull. 1996;52:58–73. https://doi.org/10.1093/oxfordjournals.bmb.a011533 .
doi: 10.1093/oxfordjournals.bmb.a011533
pubmed: 8746297
Lim J, Wirth J, Wu K, Giovannucci E, Kraft P, Turman C, et al. Obesity, adiposity, and risk of symptomatic gallstone disease according to genetic susceptibility. Clin Gastroenterol H. 2022;20:e1083–120. https://doi.org/10.1016/j.cgh.2021.06.044 .
doi: 10.1016/j.cgh.2021.06.044